Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18 25th Annual ROTH Conference Business Wire SAN DIEGO -- March 11, 2013 Cytori Therapeutics Inc. (NASDAQ: CYTX) will present and provide a corporate update from the 25^th Annual Roth Conference on Monday, March 18 at 4:30 PM PT. The presentation will be webcast and may be accessed under “Webcasts” under Cytori’s Investor Relations section of the website. The webcast can be viewed live and will be available for replay after the presentation on the Company's website. About Cytori Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution® system product family. www.cytori.com Contact: Cytori Therapeutics Inc. Megan McCormick, +1-858-875-5279 firstname.lastname@example.org
Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18
Press spacebar to pause and continue. Press esc to stop.